Advertisement

Malignant Tumors of the Female Reproductive System

  • Elisabete WeiderpassEmail author
  • Dana Hashim
  • France Labrèche
Chapter
  • 49 Downloads

Abstract

Cancers of the female reproductive system—namely, cancer of the cervix uteri (cervical cancer); cancer of the corpus uteri (which includes mostly adenocarcinomas originating in the endometrium and some other rarer cancers, such as sarcomas); ovarian, vulvar, vaginal, and fallopian tube cancers; and choriocarcinoma—are an important cause of cancer morbidity and mortality worldwide. Cervical, endometrial, and ovarian cancers are relatively common, while the other cancers of the female reproductive system are very rare. The only agent considered to be carcinogenic to the female reproductive system with sufficient evidence in humans is asbestos, classified as a carcinogen for the human ovary. Exposure to other agents with sufficient evidence of carcinogenicity generally occurs through medical treatments (diethylstilbestrol, oral contraceptives or hormone replacement therapy, X-radiation, and γ-radiation), environmental exposure (atomic bomb survivors), personal lifestyle habits (smoking, perineal use of talc-based body powder), or infections with viruses, namely, human immunodeficiency virus-1 (HIV1) and several human papilloma virus (HPV) types.

Keywords

Cervix Endometrial cancer Ovarian cancer Vulva Vagina Fallopian tube Women Cervical cancer Asbestos Occupational exposures 

Notes

Disclaimer

Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization. Dr. Hashim was at IARC at the time of writing this chapter.

References

  1. 1.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Merritt MA, Cramer DW. Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark. 2011;9:287–305.CrossRefGoogle Scholar
  3. 3.
    Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J, editors. Cancer incidence in five continents, vol. X (electronic version). Lyon: International Agency for Research on Cancer; 2013. http://ci5.iarc.fr. Accessed 31 July 2017.Google Scholar
  4. 4.
    Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24(Suppl 3):S3/11–25.CrossRefGoogle Scholar
  5. 5.
    Wagner M, Bennetts L, Patel H, Welner S, de Sanjose S, Weiss TW. Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females. Infect Agent Cancer. 2015;10:13.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Andrae B, Andersson TML, Lambert PC, Kemetli L, Silfverdal L, Strander B, et al. Screening and cervical cancer cure: a population-based cohort study. Br Med J. 2012;344:e900.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103:1827–39.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Kurman RJ, Carcangiu ML, Simon Herrington C, Young RH, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC; 2014. p. 121–51.Google Scholar
  11. 11.
    Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13:295–308.PubMedCrossRefGoogle Scholar
  12. 12.
    Sherman ME, Sturgeon S, Brinton L, Kurman RJ. Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis. J Cell Biochem Suppl. 1995;23:160–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer. 2000;89:1758–64.PubMedCrossRefGoogle Scholar
  14. 14.
    Faquin WC, Fitzgerald JT, Lin MC, Boynton KA, Muto MG, Mutter GL. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues. Am J Clin Pathol. 2000;113:576–82.PubMedCrossRefGoogle Scholar
  15. 15.
    Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94:642–6.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008;630:148–65.PubMedCrossRefGoogle Scholar
  17. 17.
    IARC. Monographs on the evaluation of carcinogenic risks to humans, a review of human carcinogens. Part E: personal habits and indoor combustions, vol. 100. Lyon: International Agency for Research on Cancer; 2012.Google Scholar
  18. 18.
    World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.Google Scholar
  19. 19.
    Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens–part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    McMeekin DS. Sarcoma of the uterus. In: DiSaia PA, Creasman WT, editors. Clinical gynecologic oncology. 7th ed. Philadelphia: Mosby Elsevier; 2007.Google Scholar
  21. 21.
    McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002;12:687–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Nordal RR, Thoresen SO. Uterine sarcomas in Norway 1956–1992: incidence, survival and mortality. Eur J Cancer. 1997;33:907–11.PubMedCrossRefGoogle Scholar
  23. 23.
    Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009;54:355–64.PubMedCrossRefGoogle Scholar
  24. 24.
    Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T, et al. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990–2003). Int J Gynecol Cancer. 2006;16:1358–63.PubMedGoogle Scholar
  25. 25.
    Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol. 2008;111:74–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol. 2004;93:204–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst. 1986;76:399–402.PubMedGoogle Scholar
  28. 28.
    Schwartz SM, Weiss NS, Daling JR, Gammon MD, Liff JM, Watt J, et al. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Cancer. 1996;77:717–24.PubMedCrossRefGoogle Scholar
  29. 29.
    Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD. Association of tamoxifen and uterine sarcoma. J Clin Oncol. 2002;20:2758–60.PubMedCrossRefGoogle Scholar
  30. 30.
    Arenas M, Rovirosa A, Hernandez V, Ordi J, Jorcano S, Mellado B, Biete A. Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer. 2006;16:861–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol. 2009;472:413–37.PubMedCrossRefGoogle Scholar
  32. 32.
    Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer. 2003;97(10 Suppl):2631–42.PubMedCrossRefGoogle Scholar
  33. 33.
    Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, Nakano H. Histological classification of ovarian cancer. Med Electron Microsc. 2003;36:9–17.PubMedCrossRefGoogle Scholar
  34. 34.
    Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsiere T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215–33.PubMedCrossRefGoogle Scholar
  35. 35.
    Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: International Agency for Research on Cancer; 2003.Google Scholar
  36. 36.
    Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878–81.PubMedCrossRefGoogle Scholar
  37. 37.
    Riska A, Leminen A. Determinants of incidence of primary fallopian tube carcinoma (PFTC). Methods Mol Biol. 2009;472:387–96.PubMedCrossRefGoogle Scholar
  38. 38.
    IARC. Agents classified by the IARC monographs, vol. 1–123. http://monographs.iarc.fr/ENG/Classification/ClassificationsGroupOrderpdf. Accessed 8 Mar 2019.
  39. 39.
    Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens–part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10:453–4.CrossRefGoogle Scholar
  40. 40.
    Concha-Barrientos M, Nelson DI, Driscoll T, Steenland NK, Punnett L, Fingerhut MA, et al. Selected occupational risk factors. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of diseases attributable to selected major risk factors, vol. 1 and 2. Geneva: World Health Organization; 2004.Google Scholar
  41. 41.
    ATSDR. Toxicological profile for asbestos. Atlanta: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention; 2001. http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=30&tid=4. Accessed Aug 2011.Google Scholar
  42. 42.
    Magnani C, Ferrante D, Barone-Adesi F, Bertolotti M, Todesco A, Mirabelli D, Terracini B. Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers. Occup Environ Med. 2008;65:164–70.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Camargo MC, Stayner LT, Straif K, et al. Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect. 2011;119:1211–7.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    IARC. Monographs on the evaluation of carcinogenic risks to humans. Dry cleaning, some chlorinated solvents and other industrial chemicals, vol. 63. Lyon: International Agency for Research on Cancer; 1995.Google Scholar
  45. 45.
    Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning workers. J Occup Med. 1994;36:867–74.PubMedGoogle Scholar
  46. 46.
    Blair A, Stewart PA, Tolbert PE, Grauman D, Moran FX, Vaught J, Rayner J. Cancer and other causes of death among a cohort of dry cleaners. Br J Ind Med. 1990;47:162–8.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Anttila A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med. 1995;37:797–806.CrossRefGoogle Scholar
  48. 48.
    Guha N, Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Baan R, Mattock H, Straif K. Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites. Lancet Oncol. 2012;13:1192–3.PubMedCrossRefGoogle Scholar
  49. 49.
    Blair A, Petralia SA, Stewart PA. Extended mortality follow-up of a cohort of dry cleaners. Ann Epidemiol. 2003;13:50–6.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Ruder AM, Ward EM, Brown DP. Mortality in dry-cleaning workers: an update. Am J Ind Med. 2001;39:121–32.PubMedCrossRefGoogle Scholar
  51. 51.
    Travier N, Gridley G, De Roos AJ, Plato N, Moradi T, Boffetta P. Cancer incidence of dry cleaning, laundry and ironing workers in Sweden. Scand J Work Environ Health. 2002;28:341–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Selden AI, Ahlborg G Jr. Cancer morbidity in Swedish dry-cleaners and laundry workers: historically prospective cohort study. Int Arch Occup Environ Health. 2011;84:435–43.PubMedCrossRefGoogle Scholar
  53. 53.
    Savitz DA, Andrews KW, Brinton LA. Occupation and cervical cancer. J Occup Environ Med. 1995;37:357–61.PubMedCrossRefGoogle Scholar
  54. 54.
    Sala M, Dosemeci M, Zahm SH. A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states. J Occup Environ Med. 1998;40:632–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Carpenter L, Roman E. Cancer and occupation in women: identifying associations using routinely collected national data. Environ Health Perspect. 1999;107(Suppl 2):299–303.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, et al. Occupation and cancer—follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48:646–790.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Czene K, Tiikkaja S, Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer. 2003;105:108–12.PubMedCrossRefGoogle Scholar
  58. 58.
    Wesseling C, Ahlbom A, Antich D, Rodriguez AC, Castro R. Cancer in banana plantation workers in Costa Rica. Int J Epidemiol. 1996;25:1125–31.PubMedCrossRefGoogle Scholar
  59. 59.
    Settimi L, Comba P, Carrieri P, Boffetta P, Magnani C, Terracini B, et al. Cancer risk among female agricultural workers: a multi-center case-control study. Am J Ind Med. 1999;36:135–41.PubMedCrossRefGoogle Scholar
  60. 60.
    Colt JS, Stallones L, Cameron LL, Dosemeci M, Zahm SH. Proportionate mortality among US migrant and seasonal farm workers in twenty-four states. Am J Ind Med. 2001;40:604–11.PubMedCrossRefGoogle Scholar
  61. 61.
    Joseph N, Nelliyanil M, Supriya K, Babu Y, Naik R, Purushothama K, Kotian SM, Angeline R, Sharavathi K, Saralaya V, Bhaskaran U, Jain A. Association between occupational history of exposure to tobacco dust and risk of carcinoma cervix: a case-control study. Indian J Cancer. 2016;53:44–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Ma F, Fleming LE, Lee DJ, Trapido E, Gerace TA. Cancer incidence in Florida professional firefighters, 1981 to 1999. J Occup Environ Med. 2006;48:883–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007;33:336–43.PubMedCrossRefGoogle Scholar
  64. 64.
    Weiderpass E, Pukkala E, Vasama-Neuvonen K, Kauppinen T, Vainio H, Paakkulainen H, et al. Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med. 2001;39:572–80.PubMedCrossRefGoogle Scholar
  65. 65.
    Hansen J, Sallmen M, Selden AI, Anttila A, Pukkala E, Andersson K, Bryngelsson IL, Raaschou-Nielsen O, Olsen JH, McLaughlin JK. Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies. J Natl Cancer Inst. 2013;10512:869–77.CrossRefGoogle Scholar
  66. 66.
    Charbotel B, Massardier-Pilonchery A, Fort E, Dananche B, Févotte J, Confavreux-Romestaing C, Bergeret A. Occupational trichloroethylene exposure and cervical pathology: a case-control study. Ann Occup Hyg. 2013;57:407–16.PubMedGoogle Scholar
  67. 67.
    Boffetta P, Dosemeci M, Gridley G, Bath H, Moradi T, Silverman D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control. 2001;12:365–74.CrossRefGoogle Scholar
  68. 68.
    Kuzmickiene I, Didziapetris R, Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania. J Occup Environ Med. 2004;46:147–53.CrossRefGoogle Scholar
  69. 69.
    Betenia N, Costello S, Eisen EA. Risk of cervical cancer among female autoworkers exposed to metalworking fluids. Scand J Work Environ Health. 2012;38:78–83.PubMedCrossRefGoogle Scholar
  70. 70.
    Laakkonen A, Verkasalo PK, Nevalainen A, Kauppinen T, Kyyronen P, Pukkala EI. Moulds, bacteria and cancer among Finns: an occupational cohort study. Occup Environ Med. 2008;65:489–93.PubMedCrossRefGoogle Scholar
  71. 71.
    Petralia SA, Dosemeci M, Adams EE, Zahm SH. Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984–1993. Am J Ind Med. 1999;36:159–65.PubMedCrossRefGoogle Scholar
  72. 72.
    Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, et al. High breast cancer incidence rates among California teachers: results from the California teachers study (United States). Cancer Causes Control. 2002;13:625–35.PubMedCrossRefGoogle Scholar
  73. 73.
    MacArthur AC, Le ND, Abanto ZU, Gallagher RP. Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950–94. Occup Med (Lond). 2007;57:246–53.CrossRefGoogle Scholar
  74. 74.
    Boffetta P, Fordyce T, Mandel JS. A mortality study of workers exposed to insoluble forms of beryllium. Eur J Cancer Prev. 2014;23:587–93.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Ruder AM, Hein MJ, Hopf NB, Waters MA. Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update. Int J Hyg Environ Health. 2014;217:176–87.CrossRefGoogle Scholar
  76. 76.
    Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007;67:10618–22.PubMedCrossRefGoogle Scholar
  77. 77.
    John EM, Koo J, Horn-Ross PL. Lifetime physical activity and risk of endometrial cancer. Cancer Epidemiol Biomark Prev. 2010;19:1276–83.CrossRefGoogle Scholar
  78. 78.
    Schmid D, Behrens G, Keimling M, Jochem C, Ricci C, Leitzmann M. A systematic review and meta-analysis of physical activity and endometrial cancer risk. Eur J Epidemiol. 2015;30:397–412.PubMedCrossRefGoogle Scholar
  79. 79.
    Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for endometrial cancer among textile workers in Shanghai, China. Am J Ind Med. 2008;51:673–9.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA data bases. Maturitas. 2012;72:56–60.PubMedCrossRefGoogle Scholar
  81. 81.
    NTP. Report on carcinogens. 14th ed. Research Triangle Park: US Department of Health and Human Services, Public Health Service, National Toxicology Program; 2016. https://ntp.niehs.nih.gov/pubhealth/roc/index-1.html.Google Scholar
  82. 82.
    IARC. Monographs on the evaluation of carcinogenic risks to humans, a review of human carcinogens. Part C: arsenic, metals, fibres, and dusts, vol. 100. Lyon: International Agency for Research on Cancer; 2009. p. 225–6.Google Scholar
  83. 83.
    Heller DS, Gordon RE, Westhoff C, Gerber S. Asbestos exposure and ovarian fiber burden. Am J Ind Med. 1996;29:435–9.PubMedCrossRefGoogle Scholar
  84. 84.
    Acheson ED, Gardner MJ, Pippard EC, Grime LP. Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year follow-up. Br J Ind Med. 1982;39:344–8.PubMedPubMedCentralGoogle Scholar
  85. 85.
    McDonald JC, Harris JM, Berry G. Sixty years on: the price of assembling military gas masks in 1940. Occup Environ Med. 2006;63:852–5.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Vasama-Neuvonen K, Pukkala E, Paakkulainen H, Mutanen P, Weiderpass E, Boffetta P, et al. Ovarian cancer and occupational exposures in Finland. Am J Ind Med. 1999;36:83–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Bulbulyan MA, Ilychova SA, Zahm SH, Astashevsky SV, Zaridze DG. Cancer mortality among women in the Russian printing industry. Am J Ind Med. 1999;36:166–71.PubMedCrossRefGoogle Scholar
  88. 88.
    IARC. Monographs on the evaluation of carcinogenic risks to humans, a review of human carcinogens. Part D: radiation, vol. 100. Lyon: International Agency for Research on Cancer; 2012.Google Scholar
  89. 89.
    United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 2008 report to the general assembly with scientific annexes, vol. 1. New York: United Nations; 2010.Google Scholar
  90. 90.
    IARC. Monographs on the evaluation of carcinogenic risks to humans, ionizing radiation. Part 1: X- and gamma (γ)-radiation, and neutrons, vol. 75. Lyon: International Agency for Research on Cancer; 2000.Google Scholar
  91. 91.
    Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, et al. Cancer incidence in the US radiologic technologists health study, 1983–1998. Cancer. 2003;97:3080–9.CrossRefGoogle Scholar
  92. 92.
    Doody MM, Mandel JS, Lubin JH, Boice JD Jr. Mortality among United States radiologic technologists, 1926–90. Cancer Causes Control. 1998;9:67–75.PubMedCrossRefGoogle Scholar
  93. 93.
    Wang JX, Zhang LA, Li BX, Zhao YC, Wang ZQ, Zhang JY, Aoyama T. Cancer incidence and risk estimation among medical x-ray workers in China, 1950–1995. Health Phys. 2002;82:455–66.PubMedCrossRefGoogle Scholar
  94. 94.
    McGeoghegan D, Binks K. The mortality and cancer morbidity experience of workers at the Springfields uranium production facility, 1946–95. J Radiol Prot. 2000;20:111–37.PubMedCrossRefGoogle Scholar
  95. 95.
    Telle-Lamberton M, Bergot D, Gagneau M, Samson E, Giraud JM, Neron MO, Hubert P. Cancer mortality among French atomic energy commission workers. Am J Ind Med. 2004;45:34–44.PubMedCrossRefGoogle Scholar
  96. 96.
    Ashmore JP, Krewski D, Zielinski JM, Jiang H, Semenciw R, Band PR. First analysis of mortality and occupational radiation exposure based on the national dose registry of Canada. Am J Epidemiol. 1998;148:564–74.PubMedCrossRefGoogle Scholar
  97. 97.
    Sont WN, Zielinski JM, Ashmore JP, Jiang H, Krewski D, Fair ME, et al. First analysis of cancer incidence and occupational radiation exposure based on the national dose registry of Canada. Am J Epidemiol. 2001;153:309–18.PubMedCrossRefGoogle Scholar
  98. 98.
    Shields T, Gridley G, Moradi T, Adami J, Plato N, Dosemeci M. Occupational exposures and the risk of ovarian cancer in Sweden. Am J Ind Med. 2002;42:200–13.PubMedCrossRefGoogle Scholar
  99. 99.
    IARC. Monographs on the evaluation of carcinogenic risks to humans, a review of human carcinogens. Part a: pharmaceuticals, vol. 100. Lyon: International Agency for Research on Cancer; 2011.Google Scholar
  100. 100.
    Heron RJ, Pickering FC. Health effects of exposure to active pharmaceutical ingredients (APIs). Occup Med (Lond). 2003;53:357–62.CrossRefGoogle Scholar
  101. 101.
    Edling C, Friis L, Mikoczy Z, Hagmar L, Lindfors P. Cancer incidence among pharmaceutical workers. Scand J Work Environ Health. 1995;21:116–23.PubMedCrossRefGoogle Scholar
  102. 102.
    Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;20:22–6.PubMedCrossRefGoogle Scholar
  103. 103.
    Hansen J, Olsen JH, Larsen AI. Cancer morbidity among employees in a Danish pharmaceutical plant. Int J Epidemiol. 1994;23:891–8.PubMedCrossRefGoogle Scholar
  104. 104.
    Ruder AM, Meyers AR, Bertke SJ. Mortality among styrene-exposed workers in the reinforced plastic boatbuilding industry. Occup Environ Med. 2016;73:97–102.PubMedCrossRefGoogle Scholar
  105. 105.
    Lerro CC, Koutros S, Andreotti G, Friesen MC, Alavanja MC, Blair A, Hoppin JA, Sandler DP, Lubin JH, Ma X, Zhang Y, Beane Freeman LE. Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study. Occup Environ Med. 2015;72:736–44.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Guo J, Kauppinen T, Kyyronen P, Heikkila P, Lindbohm ML, Pukkala E. Risk of esophageal, ovarian, testicular, kidney and bladder cancers and leukemia among Finnish workers exposed to diesel or gasoline engine exhaust. Int J Cancer. 2004;111:286–92.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Le ND, Leung A, Brooks-Wilson A, Gallagher RP, Swenerton KD, Demers PA, Cook LS. Occupational exposure and ovarian cancer risk. Cancer Causes Control. 2014;25:829–41.PubMedCrossRefGoogle Scholar
  108. 108.
    Nanni O, Ravaioli A, Bucchi L, Falcini F, Ricci R, Buiatti E, Amadori D. Relative and absolute cancer mortality of women in agriculture in northern Italy. Eur J Cancer Prev. 2005;14:337–44.PubMedCrossRefGoogle Scholar
  109. 109.
    Koutros S, Alavanja MC, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, et al. An update of cancer incidence in the agricultural health study. J Occup Environ Med. 2010;52:1098–105.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    IARC. Monographs on the evaluation of carcinogenic risks to humans, some aromatic amines, organic dyes and related exposures, vol. 99. Lyon: International Agency for Research on Cancer; 2010.Google Scholar
  111. 111.
    Takkouche B, Regueira-Mendez C, Montes-Martinez A. Risk of cancer among hairdressers and related workers: a meta-analysis. Int J Epidemiol. 2009;38:1512–31.PubMedCrossRefGoogle Scholar
  112. 112.
    Quach T, Doan-Billing PA, Layefsky M, Nelson D, Nguyen KD, Okahara L, et al. Cancer incidence in female cosmetologists and manicurists in California, 1988–2005. Am J Epidemiol. 2010;172:691–9.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Bryk S, Pukkala E, Martinsen JI, Unkila-Kallio L, Tryggvadottir L, Sparén P, Kjaerheim K, Weiderpass E, Riska A. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953–2012: a longitudinal cohort study. BJOG. 2017;124:143–9.PubMedCrossRefGoogle Scholar
  114. 114.
    Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Wong EY, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational exposures and ovarian cancer in textile workers. Epidemiology. 2008;19:244–50.PubMedCrossRefGoogle Scholar
  115. 115.
    Bhatti P, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. Nightshift work and risk of ovarian cancer. Occup Environ Med. 2013;70:231–7.PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Pukkala E, Saarni H. Cancer incidence among Finnish seafarers, 1967-92. Cancer Causes Control. 1996;7:231–9.PubMedCrossRefGoogle Scholar
  117. 117.
    Riska A, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupation and risk of primary fallopian tube carcinoma in Nordic countries. Int J Cancer. 2012;131:186–92.PubMedCrossRefGoogle Scholar
  118. 118.
    Mabuchi K, Bross DS, Kessler II. Epidemiology of cancer of the vulva. A case-control study. Cancer. 1985;55:1843–8.PubMedCrossRefGoogle Scholar
  119. 119.
    Loukovaara M, Pukkala E, Lehtovirta P, Leminen A. Epidemiology of choriocarcinoma in Finland, 1953 to 1999. Gynecol Oncol. 2004;92:252–5.PubMedCrossRefGoogle Scholar
  120. 120.
    Reid A, Heyworth J, de Klerk N, Musk AW. Asbestos exposure and gestational trophoblastic disease: a hypothesis. Cancer Epidemiol Biomark Prev. 2009;18:2895–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Elisabete Weiderpass
    • 1
    Email author
  • Dana Hashim
    • 1
    • 2
  • France Labrèche
    • 3
  1. 1.International Agency for Research on Cancer (IARC), World Health Organization (WHO)LyonFrance
  2. 2.Medicine, Haematology and OncologyIcahn School of Medicine at Mount SinaiNew YorkUSA
  3. 3.Département de Santé environnementale et santé au travail, École de santé publiqueUniversité de MontréalMontrealCanada

Personalised recommendations